Beta Bionics Inc Revenue per Employee (BBNX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Beta Bionics Inc   (NASDAQ: BBNX)
 

Beta Bionics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 30.92% in the third quarter 2026, year on year to cumulative value of $128 million, Beta Bionics Inc 's revenue per employee grew on a trailing twelve months basis to $ 304,521. The productivity of Beta Bionics Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 344 other companies have achieved higher revenue per employee. While Beta Bionics Inc 's total ranking has deteriorated compared to the previous quarter from 275 to 2672. Beta Bionics Inc has 420 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BBNX Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 30.92 % 42.26 % 61.67 % 61.17 % 62.34 %
Sales per Employee (TTM) $ 304,521 284,555 261,912 236,993 207,221
BBNX's Total Ranking # 2672 # 275 # 2466 # 0 #
Seq. Revenue Change 10.91 % 16.68 % -16.72 % 21.48 % 20.51 %

BBNX Company Profile >> Back to BBNX Efficiency Comparisons >> Compare BBNX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 345
Overall Market # 2672

Revenue per Employee Statistics
High Average Low
$ 261,912 $ 249,452 $ 236,993
(Mar 31 2026)   (Dec 31 2025)



Financial Statements
Beta Bionics Inc 's Revenue MRQ $ 36 Millions Visit BBNX's Income Statement
Beta Bionics Inc 's Revenues TTM $ 128 Millions Visit BBNX's aggregate revenue growth
What are BBNX's Sales? Visit BBNX's Sales by Segment




Other Ratios
Beta Bionics Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BBNX's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BBNX's Competitors
Revenue per Employee for BBNX's Suppliers
Revenue per Employee for BBNX's Customers

You may also want to know
BBNX's Sales Growth Rates BBNX's Pe Price to earnings ratio BBNX's Receivables Turnover Ratio BBNX's Stock Quote
BBNX's Net Income Growth Rates BBNX's Ps Price to Sales ratio BBNX's Sales per Employee BBNX's Asset Turnover Ratio
BBNX's Net Margin BBNX's Pb Price to Book ratio BBNX's Financial Strength Ratios BBNX's Dividend Payout Ratio
Date modified: 2026-10-28T09:23:15+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Alpha Pro Tech Ltd   527,967.48 $ 64.940  Million 123 
Orthofix Medical Inc   520,674.77 $ 835.683  Million 1,605 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Cardiff Lexington Corporation  503,682.17 $ 9.066  Million 18 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Gossamer Bio Inc   484,092.59 $ 78.423  Million 162 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Trisalus Life Sciences Inc   464,676.47 $ 47.397  Million 102 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Adc Therapeutics Sa  439,756.48 $ 84.873  Million 193 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
Idexx Laboratories Inc  423,970.45 $ 4,663.675  Million 11,000 
Abbott Laboratories  419,382.61 $ 48,229.000  Million 115,000 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Regenxbio Inc   414,854.45 $ 153.911  Million 371 
Teva Pharmaceutical Industries Limited  412,960.24 $ 14,020.000  Million 33,950 
Lemaitre Vascular Inc   412,119.08 $ 269.938  Million 655 
Sotera Health Company  410,083.33 $ 1,230.250  Million 3,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.